Updating

FDA Approves Moderna's mRNA Flu Vaccine

The U.S. Food and Drug Administration has approved Moderna's mRNA-based seasonal flu vaccine, the first of its kind, for older adults. The vaccine, named mFlusiva, uses the same mRNA platform as Moderna's Covid-19 shot and will be available for the upcoming flu season. The agency had initially declined to review the application before reversing course following public pressure.

4-source coverage 4 references
GuardianTIMECBSNYT
F.D.A. Approves Moderna’s mRNA Flu Vaccine NYTimes – Business
In brief

What the sources add

The mFlusiva vaccine for older people is the first made with the mRNA platform key to ending the coronavirus pandemic The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the Covid -19 pandemic, Moderna, the manufacturer, said. The shot, named mFlusiva, is intended for adults aged 50 or older. Other brands of flu…

Source coverage

Media reports

US
Guardian

The mRNA technology behind Moderna’s Covid vaccine reaches the flu

The mFlusiva vaccine for older people is the first made with the mRNA platform key to ending the coronavirus pandemic The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the Covid -19 pandemic, Moderna, the manufacturer, said. The shot, named mFlusiva, is intended for adults aged 50 or older. Other brands of flu…

US
TIME

FDA Approves the First mRNA Flu Vaccine

The shot, made by Moderna, will be available for this year's upcoming flu season.

US
CBS

FDA approves Moderna's mRNA flu vaccine after initial pushback

The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced.

F.D.A. Approves Moderna’s mRNA Flu VaccineNYTimes – Business
NYT

F.D.A. Approves Moderna’s mRNA Flu Vaccine

The agency had initially refused to even review the application but reversed course after a public outcry.